Laser Myocardial Therapies Under The Beam In Light Of J&J DIRECT Results
This article was originally published in The Gray Sheet
Executive Summary
Results of a Johnson & Johnson-sponsored trial showing that direct myocardial revascularization (DMR) technology has a placebo-comparable effect should prompt FDA to take a closer look at laser therapies for advanced heart disease patients, trial investigators suggest.